The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review

A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment ( PreMCI ) and the relationship to biological markers of Alzheimer's disease

(2018) Elizabeth A. Crocco et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline

(2017) Nare Torosyan et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment

(2017) Byungseung Moon et al.   JOURNAL OF ALZHEIMERS DISEASE

Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer’s Disease

(2017) Jordi A. Matias-Guiu et al.   JOURNAL OF ALZHEIMERS DISEASE

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database

(2017) Fayçal Ben Bouallègue et al.   Alzheimers Research & Therapy

Administration and Scoring Variance on the ADAS-Cog

(2017) Donald J. Connor et al.   JOURNAL OF ALZHEIMERS DISEASE

A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load

(2016) David A. Loewenstein et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?

(2016) B. S. Ye et al.   EUROPEAN JOURNAL OF NEUROLOGY

Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials

(2016) Richard E. Kennedy et al.   JOURNAL OF ALZHEIMERS DISEASE

Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer’s Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects

(2016) Louis De Beaumont et al.   JOURNAL OF ALZHEIMERS DISEASE

Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial

(2016) José A. Luchsinger et al.   JOURNAL OF ALZHEIMERS DISEASE

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

(2016) Jinping Wang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI

(2016) Susan M. Landau et al.   NEUROLOGY

Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies

(2016) Jana Podhorna et al.   Alzheimers Research & Therapy

Development of a straightforward and sensitive scale for MCI and early AD clinical trials

(2015) Yifan Huang et al.   Alzheimers & Dementia

Association of fish oil supplement use with preservation of brain volume and cognitive function

(2015) Lori A. Daiello et al.   Alzheimers & Dementia

Modifiable Predictors of Dementia in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis

(2015) Claudia Cooper et al.   AMERICAN JOURNAL OF PSYCHIATRY

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease

(2015) Erik Portelius et al.   BRAIN

IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia

(2015) Shawn Kile et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

New scoring methodology improves the sensitivity of the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials

(2015) Nishant Verma et al.   Alzheimers Research & Therapy

Mild cognitive impairment: a concept in evolution

(2014) R. C. Petersen et al.   JOURNAL OF INTERNAL MEDICINE

The Study of Mental and Resistance Training (SMART) Study—Resistance Training and/or Cognitive Training in Mild Cognitive Impairment: A Randomized, Double-Blind, Double-Sham Controlled Trial

(2014) Maria A. Fiatarone Singh et al.   Journal of the American Medical Directors Association

Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study

(2014) P M Doraiswamy et al.   MOLECULAR PSYCHIATRY

Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling

(2014) Sebastian Ueckert et al.   PHARMACEUTICAL RESEARCH

Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: a noncomparative, exploratory clinical study

(2014) Danilo Zanotta et al.   Neuropsychiatric Disease and Treatment

Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment

(2014) Jon B Toledo et al.   Alzheimers Research & Therapy

Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease

(2013) Richard E. Kennedy et al.   Alzheimers & Dementia

The Effect of Subsyndromal Symptoms of Depression and White Matter Lesions on Disability for Individuals with Mild Cognitive Impairment

(2013) R. Scott Mackin et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Systematic Review: Factors Associated With Risk for and Possible Prevention of Cognitive Decline in Later Life

(2013) Brenda L. Plassman   ANNALS OF INTERNAL MEDICINE

Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

(2013) Chieh-Hsin Lin et al.   BIOLOGICAL PSYCHIATRY

Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis

(2013) A. C. Tricco et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

A Randomized Controlled Trial of Multicomponent Exercise in Older Adults with Mild Cognitive Impairment

(2013) Takao Suzuki et al.   PLoS One

Cognitive interventions in healthy older adults and people with mild cognitive impairment: A systematic review

(2012) Jennifer Reijnders et al.   AGEING RESEARCH REVIEWS

Gaining precision on the Alzheimer’s Disease Assessment Scale-cognitive: A comparison of item response theory-based scores and total scores

(2012) Steve Balsis et al.   Alzheimers & Dementia

The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

(2012) Nandini Raghavan et al.   Alzheimers & Dementia

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

(2012) Susan M. Landau et al.   ANNALS OF NEUROLOGY

The Alzheimer’s Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI

(2012) Jeannine Skinner et al.   Brain Imaging and Behavior

Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

(2012) Paul K. Crane et al.   Brain Imaging and Behavior

Biomarker Positive and Negative Subjects in the ADNI Cohort: Clinical Characterization

(2012) Bentham Science Publisher   Current Alzheimer Research

Long-Term Observation of a Multicomponent Cognitive Intervention in Mild Cognitive Impairment

(2012) Verena C. Buschert et al.   JOURNAL OF CLINICAL PSYCHIATRY

Amyloid-  assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

(2012) P. M. Doraiswamy et al.   NEUROLOGY

Longitudinal Change of Biomarkers in Cognitive Decline

(2011) Raymond Y. Lo   ARCHIVES OF NEUROLOGY

Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative

(2011) Lon S. Schneider   ARCHIVES OF NEUROLOGY

Psychometric Comparison of Standard and Computerized Administration of the Alzheimers Disease Assessment Scale – Cognitive Subscale (ADASCog)

(2011) J. P. O'Halloran et al.   Current Alzheimer Research

Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease

(2011) Ralf Ihl et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment

(2011) K. Herholz et al.   JOURNAL OF NUCLEAR MEDICINE

Statins, Risk of Dementia, and Cognitive Function: Secondary Analysis of the Ginkgo Evaluation of Memory Study

(2011) Kerstin Bettermann et al.   Journal of Stroke & Cerebrovascular Diseases

Improving the Accuracy and Precision of Cognitive Testing in Mild Dementia

(2011) Hans Wouters et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Touch Panel-type Dementia Assessment Scale: a new computer-based rating scale for Alzheimer's disease

(2011) Masashi INOUE et al.   Psychogeriatrics

Body Mass Index and Cognitive Decline in Mild Cognitive Impairment

(2010) Benjamin B. Cronk et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Derivation of a New ADAS-cog Composite Using Tree-based Multivariate Analysis

(2010) Daniel A. Llano et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Adding Delayed Recall to the Alzheimer Disease Assessment Scale is Useful in Studies of Mild Cognitive Impairment But Not Alzheimer Disease

(2010) Mary Sano et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Influence of apolipoprotein E ɛ4 on rates of cognitive and functional decline in mild cognitive impairment

(2010) Danielle C. Whitehair et al.   Alzheimers & Dementia

Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations

(2009) Matthew C. Evans et al.   EUROPEAN RADIOLOGY

Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry

(2009) April J. Ho et al.   HUMAN BRAIN MAPPING

Ginkgo biloba for Preventing Cognitive Decline in Older AdultsA Randomized Trial

(2009) Beth E. Snitz   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects

(2009) Xue Hua et al.   NEUROIMAGE

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

(2009) R. C. Petersen et al.   NEUROLOGY

Frequency and course of mild cognitive impairment in a multiethnic community

(2008) Jennifer J. Manly et al.   ANNALS OF NEUROLOGY

Plasma Urate and Progression of Mild Cognitive Impairment

(2008) Michael C. Irizarry et al.   Neurodegenerative Diseases

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study

(2008) Chih-Chiang Chiu et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY